Engineering Adeno-Associated Viral Vectors for Adjustable Gene Expression
Author Information
Author(s): Fluri David A, Baba Marie Daoud-El, Fussenegger Martin
Primary Institution: Institute for Chemical and Bioengineering, ETH Zurich
Hypothesis
Can adeno-associated viral vectors be engineered for regulated transgene expression using macrolide-responsive systems?
Conclusion
Adeno-associated virus type 2 was successfully engineered to provide new tools for macrolide-adjustable transgene expression in mammalian cells and mice.
Supporting Evidence
- Recombinant adeno-associated virus vectors were designed for regulated expression of transgenes.
- High levels of adjustability and tight transgene regulation were achieved.
- In vivo studies showed successful transgene expression in mice with controlled regulation.
Takeaway
Scientists created a special virus that can turn genes on and off using a medicine called erythromycin, which could help in treating diseases.
Methodology
The study involved designing recombinant adeno-associated virus vectors, testing their performance in various cell types, and conducting in vivo studies in mice.
Limitations
The study primarily focused on specific cell types and may not generalize to all cell types or conditions.
Participant Demographics
The study involved various mammalian cell types including CHO-K1, HT-1080, NHDF, and MCF-7, as well as mice.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website